Dozens of CDC workers taking anti-anthrax drugs

Dozens of CDC workers taking anti-anthrax drugs

Posted: Updated:
The Centers for Disease Control and Prevention says that at least 52 workers are taking antibiotics as a precaution because of a lab safety problem that may have accidentally exposed them to anthrax.

So far, the CDC's occupational health clinic has seen 54 out of 86 potentially exposed employees. Only two have refused antibiotic treatment, which can cut the chances of infection after exposure to the germ. The CDC says 27 of them also began receiving an anthrax vaccine.

The safety lapse occurred when a high level biosecurity lab failed to completely inactivate anthrax samples sent to less secure labs for further research. The problem was discovered last Friday and CDC revealed it on Thursday.

By MARILYNN MARCHIONE AP Chief Medical Writer

Copyright 2014 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
ADVERTISEMENT
Bookmark and Share
  • FOX25 Slideshows

Most Popular

Stories
Videos
Compiling list...
  • FOX 25 FeaturesMore>>

  • Tell Me Something Good

    Tell Me Something Good

    Tired of all the bad news? Looking for some good news? Tell Me Something Good, does just that! FOX 25's Mike Brooks finds the good in Oklahoma and tells you all about it.
    Tired of all the bad news? Looking for some good news? Tell Me Something Good, does just that! FOX 25's Mike Brooks finds the good in Oklahoma and tells you all about it.
  • Waste Watch

    Waste Watch

    How are your tax dollars being spent? FOX 25 Waste Watch tracks whether local, state and federal governments, or any groups, are using your money wisely... or wasting it.
    How are your tax dollars being spent? FOX 25 Waste Watch tracks whether local, state and federal governments, or any groups, are using your money wisely... or wasting it.
Powered by WorldNow
Powered by 

WorldNow
All content © Copyright 2000 - 2014 WorldNow and KOKH. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.